EP07.02. MIDRIXNEO-LUNG: Safety and Immunogenicity of a Neoantigen-Presenting Autologous Dendritic Cell Therapy in Resected NSCLC Patients - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Karim Vermaelen
Meta Tag
Speaker Karim Vermaelen
Topic Early-Stage NSCLC: New Technology & Innovations
WCLC 2023 conference
dendritic cell therapy
non-small cell lung cancer
adjuvant immunotherapy
tumor neoantigens
intravenous administration
immune responses
long-lasting responses
Powered By